Proactive Investors - Run By Investors For Investors

NetScientific's Vortex Biosciences has new director

Neff has served in a number of leadership positions in healthcare companies
NetScientific's Vortex Biosciences has new director
Vortex Biosciences has a new director

NetScientific PLC (LON:NSCI) said portfolio firm and circulating tumor cell group  Vortex Biosciences has hired Deborah Neff as a non-executive director.

She will play a critical role providing strategic oversight, as its circulating tumor cell enrichment system, the VTX-1, is progressed towards commercialisation, Netscientific said.

Neff has served in a number of leadership positions in healthcare companies, including a 15-year career at Becton Dickinson & Co in executive management positions,

The planned commercial launch of the VTX-1 system is planned for the first quarter of 2017.

It is a fully automated benchtop system for capturing intact circulating tumor cells (CTCs) directly from whole blood samples without any preprocessing steps.

CTCs, shed by cancer tumors, can potentially reveal disease recurrence or disease progression earlier than imaging and more reliably compared with standard biomarkers.

Why Invest In Netscientific PLC? Read More Here

Register here to be notified of future NSCI Company articles
View full NSCI profile View Profile

Netscientific PLC Timeline

Related Articles

In the six months ended March, revenues increased 31% to £2mln
cancer cells
February 10 2017
It has already got £7.2mln of the £14.9mln it is looking to raise, which will help fund the development of two promising cancer drug candidates: RXC004 and RXC005
November 21 2016
The flagship product, CardioCel, is a bio-engineered tissue scaffold used in the heart valve repair market.

© Proactive Investors 2017

Proactive Investor UK Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use